Skip to main content
Caplight Logo









Breathomix

Breathomix

Private
LoosdrechtHealthcare & Life Scienceshttps://www.breathomix.com/

Total Funding Raised

$758,000

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Breathomix is a medical technology company that provides a device and AI-enabled platform for respiratory health diagnosis.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Medical AI, Precision Medicine, Clinical Trials

Business Model

B2B

Customer Profile

Hardware + Subscription, Usage-Based SaaS, Services & Consulting, Data as a Service

AI Layer

Application

Keywords

breath analysisnon-invasive diagnosticselectronic noseeNoseAI-powered diagnosticsbreathomicsmedical AIearly disease detectionbreathalyzer diagnosticsprecision medicinepoint-of-care diagnosticsvolatile organic compoundsVOC analysisrespiratory disease diagnosticsoncology diagnosticsmedical devicediagnostic SaaSdigital olfaction

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Breathomix Comparables

Compare Breathomix with similar companies based on industry and business-model similarity.

Breathomix comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Nanose Medical
88%
The eNose Company
86%
BreathDX
85%

Breathomix Funding Rounds

Historical fundraising activity

View Full Funding History

Access detailed round history, amounts raised, valuations, and investors.

Key People

Founding team and executive leadership

Rianne de Vries

Chief Executive Officer

Executive Team

Breathomix Investors

Notable investors and investment history

Breathomix investors
InvestorRounds
Life Sciences @ Work Venture ChallengeAccelerator
LongfondsGrant
CbusineZGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 20, 2026

    Open roles increased from 0 to 27, representing 13.5x headcount.

  • Jan 27, 2026

    Monthly visitors grew 362% MoM, reaching 3K.

Breathomix Filings

Explore SEC and related filing metadata, where available.

Breathomix filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Breathomix's valuation, stock price, and market status.

Is Breathomix a public or private company?

Breathomix is a private company.

What is the current stock price of Breathomix?

Breathomix is a private company with no public stock price. No recent secondary market data is available.

How much is Breathomix worth (valuation)?

Valuation information for Breathomix is not publicly available.

Can I buy Breathomix stock?

Breathomix shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Breathomix's last funding round?

Funding round information for Breathomix is not publicly available.

Who are the main investors in Breathomix?

Key investors in Breathomix include Life Sciences @ Work Venture Challenge, Longfonds, CbusineZ.

Will Breathomix IPO soon?

No public IPO plans have been announced for Breathomix.

How can I track Breathomix secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Breathomix's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersLoosdrecht
Employee Range2
Year Founded2018
Last Funding—

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?